39 results on '"Pucci, Francesca"'
Search Results
2. Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial
3. Pegylated liposomal doxorubicin, 5-fluorouracil and cisplatin versus mitomycin-C, 5-fluorouracil and cisplatin for advanced gastric cancer: a randomized phase II trial
4. Everolimus in combination with octreotide long-acting repeatable in a first-line setting for patients with neuroendocrine tumors: An ITMO group study
5. sj-docx-1-onc-10.1177_11795549211043427 – Supplemental material for Clinical Impact of COVID-19 Outbreak on Cancer Patients: A Retrospective Study
6. TremelImumab and Durvalumab Combination for the Non-OperatIve Management (NOM) of Microsatellite InstabiliTY (MSI)-High Resectable Gastric or Gastroesophageal Junction Cancer: The Multicentre, Single-Arm, Multi-Cohort, Phase II INFINITY Study
7. Clinical Impact of COVID-19 Outbreak on Cancer Patients: A Retrospective Study
8. Randomised phase II trial of CAPTEM or FOLFIRI as SEcond-line therapy in NEuroendocrine CArcinomas and exploratory analysis of predictive role of PET/CT imaging and biological markers (SENECA trial): a study protocol
9. Association of high TUBB3 with resistance to adjuvant docetaxel-based chemotherapy in gastric cancer: translational study of ITACA-S
10. Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial
11. Supplementary_Figure_1 – Supplemental material for Association of high TUBB3 with resistance to adjuvant docetaxel-based chemotherapy in gastric cancer: translational study of ITACA-S
12. Prospective, randomized trial to test the efficacy of a new modality of delivering information and support to cancer patients in the Italian oncological divisions. A GICO study (Group for the Study of the Information and Communication in Oncology)
13. LACK OF RESISTANCE TO OXALIPLATIN (L-OHP)-BASED CHEMOTHERAPY IN PATIENTS (PTS) WITH ADVANCED GASTRIC CANCER PREVIOUSLY TREATED WITH CISPLATIN-CONTAINING REGIMENS: PRELIMINARY RESULTS OF A PHASE II STUDY: 2200
14. GICO RESEARCH PROGRAMME FOR THE IMPROVEMENT OF PATIENT INFORMATION AND COMMUNICATION IN ITALIAN ONCOLOGICAL DIVISIONS: ACQUIRED RESULTS, PRESENT SITUATION AND PERSPECTIVES.
15. Rechallenge for Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and Irinotecan
16. Abstract CT088: Efficacy of anti-EGFR rechallenge in RAS and BRAF wt metastatic colorectal cancer: Clinical and translational results of the phase II CRICKET study by GONO
17. Association of high TUBB3 with resistance to adjuvant docetaxel-based chemotherapy in gastric cancer: translational study of ITACA-S
18. Pulmonary metastasectomy for colorectal cancer: analysis of prognostic factors affecting survival
19. Rezension: Marco Leonzio: L’Etna, il vino, i mercanti. Dimensione locale e processi di mondializzazione (1865-1906) (rezensiert von Francesca Pucci)
20. Rezension: Michela Badii: Cibo in festa tra tradizioni e trasformazione. Pratiche e rappresentazioni in un contesto mezzadrile (rezensiert von Francesca Pucci)
21. Phase II study of everolimus in combination with octreotide LAR in first line setting for patients with neuroendocrine tumors (I.T.M.O. study): A 4-year update.
22. Updated overall survival and time to progression results in NETs treated with everolimus combination with octreotide LAR as first-line treatment.
23. Colorectal cancer patient on maintenance dialysis successfully treated with cetuximab
24. In vino veritas. Per una riflessione sulla cultura del vino nei proverbi italiani
25. Everolimus in combination with octreotide LAR as the first-line treatment for advanced neuroendocrine tumors: A phase II trial of the I.T.M.O. (Italian Trials in Medical Oncology) group.
26. Pegylated liposomal doxorubicin, 5-fluorouracil and cisplatin versus mitomycin-C, 5-fluorouracil and cisplatin for advanced gastric cancer: a randomized phase II trial
27. Capecitabine and Mitomycin c May be an Effective Treatment Option for Third-line Chemotherapy in Advanced Colorectal Cancer
28. Compliance and Outcomes in Locally Advanced Head and Neck Cancer Patients Treated with Alternating Chemoradiotherapy in Clinical Practice
29. “Misura” Project: A Retrospective Survey on the Use of 5fluorouracil in the Treatment of Colorectal Cancer in 24 Italian Clinical Centers
30. Modulation of Fluorouracil by Methotrexate, Leucovorin, and Cisplatin (M-FLP) in the Treatment of Advanced Pancreatic Cancer
31. Effects of antihypertensive drugs on glomerular function in normotensive and hypertensive subjects
32. Tremelimumab and durvalumab combination for the non-operative management (Nom) of microsatellite instability (msi)-high resectable gastric or gastroesophageal junction cancer: The multicentre, single-arm, multi-cohort, phase ii infinity study
33. Colorectal cancer patient on maintenance dialysis successfully treated with cetuximab
34. Long-term results of preoperative 5-fluorouracil-oxaliplatin chemoradiation therapy in locally advanced rectal cancer
35. Advanced stage gastric cancer and neoadjuvant chemotherapy: our experience in surgical resectability.
36. Long-term results of preoperative 5-fluorouracil-oxaliplatin chemoradiation therapy in locally advanced rectal cancer.
37. Analysis of risk factors for complications in 262 cases of laparoscopic colectomy.
38. Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial.
39. Compliance and outcomes in locally advanced head and neck cancer patients treated with alternating chemo-radiotherapy in clinical practice.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.